Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 11/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | ELANE | P08246 | 1/20 | 0.36 |
| ▸ | DRD1 | P21728 | 4/20 | 0.35 |
| ▸ | PTPRC | P08575 | 1/20 | 0.35 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.35 |
| ▸ | DRD2 | P14416 | 1/20 | 0.35 |
| ▸ | DRD4 | P21917 | 1/20 | 0.35 |
| ▸ | DRD5 | P21918 | 1/20 | 0.35 |
| ▸ | DRD3 | P35462 | 1/20 | 0.35 |
| ▸ | TDP2 | O95551 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2392834 | 0.88 | PDK2 (0.45) | PDK2ALDH1A1PTPRC | |
| SCHEMBL12781932 | 0.87 | PDK2 (0.49) | PDK2ALDH1A1PTPRCSLC6A3TDP2 | |
| SCHEMBL6292662 | 0.87 | PDK2 (0.51) | PDK2PTPRC | |
| SCHEMBL14269410 | 0.87 | PDK2 (0.51) | PDK2PTPRC | |
| SCHEMBL21730592 | 0.86 | PDK2 (0.41) | PDK2ALDH1A1PTPRCSLC6A3TDP2 | |
| SCHEMBL26155068 | 0.85 | PDK2 (0.50) | PDK2ALDH1A1TDP2 | |
| SCHEMBL14189338 | 0.85 | PDK2 (0.50) | PDK2ALDH1A1TDP2 | |
| SCHEMBL30823857 | 0.85 | PDK2 (0.50) | PDK2ALDH1A1TDP2 | |
| SCHEMBL12781934 | 0.83 | PDK2 (0.46) | PDK2ALDH1A1SLC6A3TDP2 | |
| SCHEMBL15183712 | 0.83 | PDK2 (0.46) | PDK2ALDH1A1SLC6A3TDP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2371813-A1 | Spirobifluorene-based compound and dye-sensitized solar cell using the same | Samsung SDI Co., Ltd. (KR) | 2011-10-05 | — | — | EP | disclosed |
| US-20110232763-A1 | SPIROBIFLUORENE-BASED COMPOUND AND DYE-SENSITIZED SOLAR CELL USING THE SAME | SAMSUNG SDI CO., LTD. (KR) | 2011-09-29 | — | — | US | disclosed |
| US-20110232763-A1 | SPIROBIFLUORENE-BASED COMPOUND AND DYE-SENSITIZED SOLAR CELL USING THE SAME | SAMSUNG SDI CO., LTD. (KR) | 2011-09-29 | — | — | US | disclosed |
| US-20110232763-A1 | SPIROBIFLUORENE-BASED COMPOUND AND DYE-SENSITIZED SOLAR CELL USING THE SAME | SAMSUNG SDI CO., LTD. (KR) | 2011-09-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110232763-A1 | SPIROBIFLUORENE-BASED COMPOUND AND DYE-SENSITIZED SOLAR CELL USING THE SAME | TRPA1, FDFT1, STOM | PDK2 283/4885ALDH1A1 384/4885ELANE 2120/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.